As employers consider whether to add GLP-1 drugs for weight loss to their health plans, one central question is whether these medications can help reduce long-term costs.
The hope is that when employees lose weight with the help of these drugs, they’ll experience fewer complications from chronic conditions such as diabetes and hypertension, resulting in downstream cost savings for employers covering their health pl
ans.A recent analysis from Aon provides some promising data points to support this
https://www.hr-brew.com/stories/2026/01/15/employer-health-spending-slows-glp1s?utm_source=&utm_medium=syndication&utm_campaign=feed